| Literature DB >> 31022698 |
Paolo Manzanillo1, Maria Mouchess2, Naruhisa Ota2, Bingbing Dai2, Ryan Ichikawa3, Arthur Wuster4, Benjamin Haley5, Gabriela Alvarado2, Youngsu Kwon6, Roger Caothien5, Meron Roose-Girma5, Soren Warming5, Brent S McKenzie6, Mary E Keir3, Alexis Scherl7, Wenjun Ouyang1, Tangsheng Yi1.
Abstract
Intestinal epithelial cells form a physical barrier that is tightly regulated to control intestinal permeability. Proinflammatory cytokines, such as TNF-α, increase epithelial permeability through disruption of epithelial junctions. The regulation of the epithelial barrier in inflammatory gastrointestinal disease remains to be fully characterized. In this article, we show that the human inflammatory bowel disease genetic susceptibility gene C1ORF106 plays a key role in regulating gut epithelial permeability. C1ORF106 directly interacts with cytohesins to maintain functional epithelial cell junctions. C1orf106-deficient mice are hypersensitive to TNF-α-induced increase in epithelial permeability, and this is associated with increased diarrhea. This study identifies C1ORF106 as an epithelial cell junction protein, and the loss of C1ORF106 augments TNF-α-induced intestinal epithelial leakage and diarrhea that may play a critical role in the development of inflammatory bowel disease.Entities:
Mesh:
Substances:
Year: 2018 PMID: 31022698 DOI: 10.4049/immunohorizons.1800027
Source DB: PubMed Journal: Immunohorizons ISSN: 2573-7732